Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108


Gray matter SWI-filtered phase and atrophy are linked to disability in MS.

Hagemeier J, Weinstock-Guttman B, Heininen-Brown M, Poloni GU, Bergsland N, Schirda C, Magnano CR, Kennedy C, Carl E, Dwyer MG, Minagar A, Zivadinov R.

Front Biosci (Elite Ed). 2013 Jan 1;5:525-32.


Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.

Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J, Benedict RH, Weinstock-Guttman B, Dwyer MG.

Neuroimage. 2012 Jan 2;59(1):331-9. doi: 10.1016/j.neuroimage.2011.07.045. Epub 2011 Jul 27.


Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy.

Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG, Zivadinov R.

AJNR Am J Neuroradiol. 2012 Sep;33(8):1596-601. doi: 10.3174/ajnr.A3030. Epub 2012 Mar 29.


Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis.

Hagemeier J, Yeh EA, Brown MH, Bergsland N, Dwyer MG, Carl E, Weinstock-Guttman B, Zivadinov R.

Mult Scler. 2013 Apr;19(5):567-76. doi: 10.1177/1352458512459289. Epub 2012 Sep 11.


Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.

Bergsland N, Horakova D, Dwyer MG, Dolezal O, Seidl ZK, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R.

AJNR Am J Neuroradiol. 2012 Sep;33(8):1573-8. doi: 10.3174/ajnr.A3086. Epub 2012 Apr 12.


A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.

Zivadinov R, Dwyer M, Markovic-Plese S, Hayward B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Dangond F, Weinstock-Guttman B.

Ther Adv Neurol Disord. 2015 Mar;8(2):59-70. doi: 10.1177/1756285615572953.


Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.

Zivadinov R, Schirda C, Dwyer MG, Haacke ME, Weinstock-Guttman B, Menegatti E, Heininen-Brown M, Magnano C, Malagoni AM, Wack DS, Hojnacki D, Kennedy C, Carl E, Bergsland N, Hussein S, Poloni G, Bartolomei I, Salvi F, Zamboni P.

Int Angiol. 2010 Apr;29(2):158-75.


Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study.

Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Patti F, Zivadinov R.

AJNR Am J Neuroradiol. 2014 May;35(5):912-9. doi: 10.3174/ajnr.A3788. Epub 2013 Dec 12.


The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.

Sanfilipo MP, Benedict RH, Sharma J, Weinstock-Guttman B, Bakshi R.

Neuroimage. 2005 Jul 15;26(4):1068-77. Epub 2005 Apr 20.


Iron deposition in the precentral grey matter in patients with multiple sclerosis: a quantitative study using susceptibility-weighted imaging.

Rumzan R, Wang JJ, Zeng C, Chen X, Li Y, Luo T, Lv F, Wang ZP, Hou H, Huang F.

Eur J Radiol. 2013 Feb;82(2):e95-9. doi: 10.1016/j.ejrad.2012.09.006. Epub 2012 Oct 16.


T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.

Bakshi R, Benedict RH, Bermel RA, Caruthers SD, Puli SR, Tjoa CW, Fabiano AJ, Jacobs L.

Arch Neurol. 2002 Jan;59(1):62-8.


Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals.

Hagemeier J, Dwyer MG, Bergsland N, Schweser F, Magnano CR, Heininen-Brown M, Ramasamy DP, Carl E, Kennedy C, Melia R, Polak P, Deistung A, Geurts JJ, Reichenbach JR, Zivadinov R.

AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2144-51. doi: 10.3174/ajnr.A3569. Epub 2013 May 30.


Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis.

Neema M, Arora A, Healy BC, Guss ZD, Brass SD, Duan Y, Buckle GJ, Glanz BI, Stazzone L, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R.

J Neuroimaging. 2009 Jan;19(1):3-8. doi: 10.1111/j.1552-6569.2008.00296.x.


Multiple sclerosis: improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging.

Rudko DA, Solovey I, Gati JS, Kremenchutzky M, Menon RS.

Radiology. 2014 Sep;272(3):851-64. doi: 10.1148/radiol.14132475. Epub 2014 May 14.


Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging.

Ge Y, Jensen JH, Lu H, Helpern JA, Miles L, Inglese M, Babb JS, Herbert J, Grossman RI.

AJNR Am J Neuroradiol. 2007 Oct;28(9):1639-44. Epub 2007 Sep 24.


3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study.

Zhang Y, Metz LM, Yong VW, Mitchell JR.

J Neurol Sci. 2010 Oct 15;297(1-2):76-81. doi: 10.1016/j.jns.2010.07.014. Epub 2010 Aug 12.


Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study.

Khalil M, Langkammer C, Ropele S, Petrovic K, Wallner-Blazek M, Loitfelder M, Jehna M, Bachmaier G, Schmidt R, Enzinger C, Fuchs S, Fazekas F.

Neurology. 2011 Nov 1;77(18):1691-7. doi: 10.1212/WNL.0b013e318236ef0e. Epub 2011 Oct 5.


Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter.

Ge Y, Grossman RI, Udupa JK, Babb JS, Nyúl LG, Kolson DL.

Radiology. 2001 Sep;220(3):606-10.


Gray matter atrophy is related to long-term disability in multiple sclerosis.

Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH.

Ann Neurol. 2008 Sep;64(3):247-54. doi: 10.1002/ana.21423. Erratum in: Ann Neurol. 2009 Feb;65(2):232.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk